Example: Heart Attack
Search clinical trials for: Bitter Orange
Total 1 results
-
NCT01680484CompletedConditions: Nonreassuring Fetal Status
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Carcinoma of Anal Canal
- Combat Stress Disorders
- Computers, Handheld
- Dental Restoration
- ENTONOX
- Endogenous Hyperinsulinaemic Hypoglycaemia
- Generalized Adult Periodontitis
- Mandibular Hypoplasia
- Niemann-Pick Disease
- Pityriasis Alba
- ROSE Cluster 1
- Uterine Fibroids and Heavy Menstrual Bleeding
- the Focus of the Study is Macrophage-induced Chemoresistance in Pancreatic Carcinoma Cells During Chemotherapy.
- View Full List
Sponsors and Collaborators
- Alessandra Mangia
- Arbelaez, Ana Maria
- Clément Sophie
- Delaware Department of Probation & Parole
- Innovative Med Concepts, LLC
- Institute of Myology
- International Group of Endovascular Oncology
- Jonsson Comprehensive Cancer Center
- Mikrobiomik S.L
- Revitalize Physical Therapy
- Scottish School of Primary Care
- Troels Wienecke
- UNIVERZA V LJUBLJANI (UL), SI
- View Full List
Drug Interventions
- 18F-DCFPyL Injection
- Adapalene Lotion Vehicle
- BI 1356 placebo
- Budesonide/Procaterol 180/10 X 4 puffs
- Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV])
- GLS-1200
- Icatibant (subcutaneous) and plazebo (intravenous)
- Intranasal corticosteroid
- Methotrexate 1 GM Injection
- Pain relief for pressure ulcers
- Period I : HKB0701 and SLM0807, Period II : CJ30001, Period III : HKB0701
- Tamsulosin and avanafil
- betahistine dihydrochloride
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations